QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 raymond-james-maintains-outperform-on-becton-dickinson-lowers-price-target-to-270

Raymond James analyst Jayson Bedford maintains Becton Dickinson (NYSE:BDX) with a Outperform and lowers the price target fro...

 becton-dickinson-q3-2024-adj-eps-350-beats-331-estimate-sales-4990b-miss-5076b-estimate

Becton, Dickinson (NYSE:BDX) reported quarterly earnings of $3.50 per share which beat the analyst consensus estimate of $3.31 ...

 stifel-maintains-buy-on-becton-dickinson-raises-price-target-to-280

Stifel analyst Rick Wise maintains Becton Dickinson (NYSE:BDX) with a Buy and raises the price target from $270 to $280.

Core News & Articles

The joint offerings will range from exploratory panel development to the manufacturing and distribution of FDA-approved diagnos...

 cdc-says-disruptions-in-availability-of-becton-dickinson-bactec-blood-culture-bottles-blood-culture-bottles-issuing-health-alert-network-to-inform-critical-shortage-of-becton-dickinson-bactec-blood-culture-media-bottles-becton-dickinson-bactec-shortage-has-potential-to-disrupt-patient-care-by-leading-to-delays-in-diagnosis-misdiagnosis-or-other-challenges

- Reuters

 insulin-device-maker-embecta-weighs-sale-after-70-share-decline-following-becton-dickinson-spin-off

Embecta is exploring a potential sale after a nearly 70% drop in share price since its spin-off from Becton Dickinson. The comp...

 unitedhealth-edwards-lifesciences-first-citizens-bank-and-more-cnbcs-final-trades

UnitedHealth Group was declared a "solid" healthcare company on CNBC. Cantor Fitzgerald analyst Sarah James maintains a...

 citigroup-maintains-neutral-on-becton-dickinson-lowers-price-target-to-255

Citigroup analyst Joanna Wiensch maintains Becton Dickinson (NYSE:BDX) with a Neutral and lowers the price target from $260 ...

 fda-says--aware-that-us-is-experiencing-interruptions-in-the-supply-of-bd-bactec-blood-culture-media-bottles-because-of-recent-supplier-issues

- Reuters

 becton-dickinson-says-it-has-surpassed-its-scope-1-and-2-science-based-greenhouse-gas-ghg-emissions-reduction-targets-for-fy-2023-by-5-percentage-points

 This furthers the company's progress toward its goal to reach net zero GHG emissions across its value chain by FY 2050

 evercore-isi-group-maintains-outperform-on-becton-dickinson-lowers-price-target-to-285

Evercore ISI Group analyst Vijay Kumar maintains Becton Dickinson (NYSE:BDX) with a Outperform and lowers the price target f...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION